These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20550696)

  • 1. Invasive lobular carcinoma with extracellular mucin production and HER-2 overexpression: a case report and further case studies.
    Yu J; Bhargava R; Dabbs DJ
    Diagn Pathol; 2010 Jun; 5():36. PubMed ID: 20550696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ductal phenotypic expression of the E-cadherin/catenin complex in tubulolobular carcinoma of the breast: an immunohistochemical and clinicopathologic study.
    Esposito NN; Chivukula M; Dabbs DJ
    Mod Pathol; 2007 Jan; 20(1):130-8. PubMed ID: 17143261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cadherin-catenin complex dissociation in lobular neoplasia of the breast.
    Morrogh M; Andrade VP; Giri D; Sakr RA; Paik W; Qin LX; Arroyo CD; Brogi E; Morrow M; King TA
    Breast Cancer Res Treat; 2012 Apr; 132(2):641-52. PubMed ID: 22080244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility of E-cadherin and P120 catenin cocktail immunostain in distinguishing DCIS from LCIS.
    Li X; Schwartz MR; Ro J; Hamilton CR; Ayala AG; Truong LD; Zhai QJ
    Int J Clin Exp Pathol; 2014; 7(5):2551-7. PubMed ID: 24966968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions.
    Sarrió D; Pérez-Mies B; Hardisson D; Moreno-Bueno G; Suárez A; Cano A; Martín-Pérez J; Gamallo C; Palacios J
    Oncogene; 2004 Apr; 23(19):3272-83. PubMed ID: 15077190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases.
    Sneige N; Wang J; Baker BA; Krishnamurthy S; Middleton LP
    Mod Pathol; 2002 Oct; 15(10):1044-50. PubMed ID: 12379750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive lobular carcinoma with extracellular mucin as a distinct variant of lobular carcinoma: a case report.
    Haltas H; Bayrak R; Yenidunya S; Kosehan D; Sen M; Akin K
    Diagn Pathol; 2012 Aug; 7():91. PubMed ID: 22867429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between E-cadherin and p120 expression in invasive ductal breast cancer with a lobular component and MRI findings.
    El Sharouni MA; Postma EL; van Diest PJ
    Virchows Arch; 2017 Dec; 471(6):707-712. PubMed ID: 28779344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive lobular carcinoma with extracellular mucin production-a novel pattern of lobular carcinomas of the breast. Clinico-pathological description of eight cases.
    Cserni G; Floris G; Koufopoulos N; Kovács A; Nonni A; Regitnig P; Stahls A; Varga Z
    Virchows Arch; 2017 Jul; 471(1):3-12. PubMed ID: 28528509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum of morphomolecular abnormalities of the E-cadherin/catenin complex in pleomorphic lobular carcinoma of the breast.
    Dabbs DJ; Kaplai M; Chivukula M; Kanbour A; Kanbour-Shakir A; Carter GJ
    Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):260-6. PubMed ID: 17721269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of HER2 overexpression with gene amplification and its relation to chromosome 17 aneuploidy: a 5-year experience with invasive ductal and lobular carcinomas.
    Nassar A; Khoor A; Radhakrishnan R; Radhakrishnan A; Cohen C
    Int J Clin Exp Pathol; 2014; 7(9):6254-61. PubMed ID: 25337277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Invasive lobular carcinoma of basal-like subtype of breast: a clinicopathologic analysis].
    Zhang LY; Gao LX; Liu G; Yang GZ; Cheng J; Ding HY
    Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):599-603. PubMed ID: 24314245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of Pathological Criteria and Immunohistochemical Evaluation for Invasive Lobular Carcinoma Diagnosis: Recommendations From the European Lobular Breast Cancer Consortium.
    De Schepper M; Koorman T; Richard F; Christgen M; Vincent-Salomon A; Schnitt SJ; van Diest PJ; Zels G; Mertens F; Maetens M; Vanden Bempt I; Harbeck N; Nitz U; Gräser M; Kümmel S; Gluz O; Weynand B; Floris G; Derksen PWB; Desmedt C;
    Mod Pathol; 2024 Jul; 37(7):100497. PubMed ID: 38641322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive Lobular Carcinoma With Extracellular Mucin: Not All Mucinous Mammary Carcinomas Are Ductal!
    Singh K; DiazGomez B; Wang Y; Ou J; Hansen K
    Int J Surg Pathol; 2019 Feb; 27(1):55-58. PubMed ID: 30032676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast.
    Mastracci TL; Tjan S; Bane AL; O'Malley FP; Andrulis IL
    Mod Pathol; 2005 Jun; 18(6):741-51. PubMed ID: 15696125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements.
    Christgen M; Bartels S; van Luttikhuizen JL; Bublitz J; Rieger LU; Christgen H; Stark H; Sander B; Lehmann U; Steinemann D; Derksen PWB; Kreipe H
    Mod Pathol; 2020 Dec; 33(12):2483-2498. PubMed ID: 32572153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression pattern of E-cadherin and p120-catenin in infiltrating lobular carcinoma and ductal carcinoma of the breast and its significance].
    Li L; Bi XF; Xu X; Liu XY; Shen GH; Guo L; Yuan YL; Wang F; Wang MR; Yang HY
    Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):273-7. PubMed ID: 20510078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology.
    McCart Reed AE; Kutasovic JR; Nones K; Saunus JM; Da Silva L; Newell F; Kazakoff S; Melville L; Jayanthan J; Vargas AC; Reid LE; Beesley J; Chen XQ; Patch AM; Clouston D; Porter A; Evans E; Pearson JV; Chenevix-Trench G; Cummings MC; Waddell N; Lakhani SR; Simpson PT
    J Pathol; 2018 Apr; 244(4):460-468. PubMed ID: 29344954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differential diagnosis of invasive ductal carcinoma versus invasive lobular carcinoma of breast].
    Yin HF; Li T; Zhang H; Zhang S
    Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):663-7. PubMed ID: 20078969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness and limitations of E-cadherin and β-catenin in the classification of breast carcinomas in situ with mixed pattern.
    Gomes DS; Porto SS; Rocha RM; Gobbi H
    Diagn Pathol; 2013 Jul; 8():114. PubMed ID: 23837653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.